Then, we found that overexpression of LMP1 activated the MEK1/2/Nrf-2 signaling pathway in the SNK-6 and KHYG-1 cell lines, and that the inhibition of MEK1/2/Nrf-2 blocked the promoting function of LMP1 in lymphoma cell resistance. This evidence concerns the gene PDLIM7 and lymphoma.